Correlation Between Sprint Bioscience and AlzeCure Pharma
Can any of the company-specific risk be diversified away by investing in both Sprint Bioscience and AlzeCure Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sprint Bioscience and AlzeCure Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sprint Bioscience AB and AlzeCure Pharma, you can compare the effects of market volatilities on Sprint Bioscience and AlzeCure Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sprint Bioscience with a short position of AlzeCure Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sprint Bioscience and AlzeCure Pharma.
Diversification Opportunities for Sprint Bioscience and AlzeCure Pharma
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Sprint and AlzeCure is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Sprint Bioscience AB and AlzeCure Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AlzeCure Pharma and Sprint Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sprint Bioscience AB are associated (or correlated) with AlzeCure Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AlzeCure Pharma has no effect on the direction of Sprint Bioscience i.e., Sprint Bioscience and AlzeCure Pharma go up and down completely randomly.
Pair Corralation between Sprint Bioscience and AlzeCure Pharma
Assuming the 90 days trading horizon Sprint Bioscience AB is expected to generate 0.9 times more return on investment than AlzeCure Pharma. However, Sprint Bioscience AB is 1.11 times less risky than AlzeCure Pharma. It trades about 0.0 of its potential returns per unit of risk. AlzeCure Pharma is currently generating about -0.09 per unit of risk. If you would invest 179.00 in Sprint Bioscience AB on October 22, 2024 and sell it today you would lose (12.00) from holding Sprint Bioscience AB or give up 6.7% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sprint Bioscience AB vs. AlzeCure Pharma
Performance |
| Timeline |
| Sprint Bioscience |
| AlzeCure Pharma |
Sprint Bioscience and AlzeCure Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sprint Bioscience and AlzeCure Pharma
The main advantage of trading using opposite Sprint Bioscience and AlzeCure Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sprint Bioscience position performs unexpectedly, AlzeCure Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AlzeCure Pharma will offset losses from the drop in AlzeCure Pharma's long position.| Sprint Bioscience vs. Cantargia AB | Sprint Bioscience vs. Saniona AB | Sprint Bioscience vs. Acarix AS | Sprint Bioscience vs. Gabather AB |
| AlzeCure Pharma vs. Systemair AB | AlzeCure Pharma vs. Nitro Games Oyj | AlzeCure Pharma vs. FormPipe Software AB | AlzeCure Pharma vs. USWE Sports AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |